We are pleased to announce that our Zepto Capsulotomy System has been approved for sale in Canada by the Therapeutic Products Directorate of the Medical Devices Bureau. Ophthalmologists in Canada may now order and use Zepto in their cataract surgeries.
Mynosys Cellular Devices Inc. receives import authority from South Korea and announces Zepto® entry into the South Korean market. Read full press release ... [ read more ]
Mynosys will be exhibiting its new Zepto Capsulotomy System at the ESCRS show in Lisbon in September, 2018.